Erectile dysfunction: The need to be evaluated, the right to be treated - 21/08/11
, Robert F. DeBusk, MD b, Graham Jackson, MD, FRCP cRésumé |
Erectile dysfunction (ED) is commonly associated with cardiovascular disease, which has potentially fatal consequences if not managed appropriately. Physicians and patients for a number of reasons commonly ignore ED. Increased awareness of the health consequences of ED would encourage men and health care professionals to address this condition more freely, permitting appropriate screening and treatment of cardiovascular disease.
Concerns about the risks of treating ED in the cardiac patient should not prevent ED from being discussed and we suggest that early acknowledgment of ED might prevent cardiovascular morbidity and even mortality. Specific guidelines for the management of ED in cardiac patients, produced by 2 expert panels, can also be applied to men without known cardiovascular disease.
Le texte complet de cet article est disponible en PDF.Plan
Vol 150 - N° 4
P. 620-626 - octobre 2005 Retour au numéro
Article précédent
- Treating depression after myocardial infarction: Can selecting patients on the basis of genetic susceptibility improve psychiatric and medical outcomes?
- Redford B. Williams
- Design and methodology of the Occluded Artery Trial (OAT)
- The Occluded Artery Trial (OAT) Research Group a, Judith S. Hochman, Gervasio A. Lamas, Genell L. Knatterud, Christopher E. Buller, Vladimir Dzavik, Daniel B. Mark, Harmony R. Reynolds, Harvey D. White
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?